| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,023 |
2,837 |
$98K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
723 |
600 |
$25K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,236 |
1,868 |
$18K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
607 |
522 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,365 |
791 |
$11K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
96 |
91 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
126 |
118 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
514 |
390 |
$4K |
| 99000 |
|
465 |
415 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
126 |
114 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
34 |
29 |
$2K |
| 87807 |
|
147 |
130 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
66 |
51 |
$412.50 |
| 81003 |
|
124 |
107 |
$132.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
149 |
121 |
$25.64 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
88 |
74 |
$13.05 |
| 90651 |
|
16 |
14 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
427 |
368 |
$0.00 |
| 90461 |
|
39 |
28 |
$0.00 |